Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors

Abstract: The X-ray structure of the catalytic domain of the EphA3 tyrosine kinase in complex with a previously reported type II inhibitor was used to design two novel quinoxaline derivatives, inspired by kinase inhibitors that have reached clinical development. These two new compounds were characterized by an array of cell-based assays and gene expression profiling experiments. A global chemical proteomics approach was used to generate the drug-protein interaction profile, which suggested suitable therapeutic indications. Both inhibitors, studied in the context of angiogenesis and in vivo in a relevant lymphoma model, showed high efficacy in the control of tumor size

Sprache
Englisch
Umfang
Online-Ressource
Anmerkungen
RSC medicinal chemistry. - 11, 6 (2020) , 665-675, ISSN: 2040-2511
Standort
Deutsche Nationalbibliothek Frankfurt am Main

Urheber
Unzue, Andrea
Jessen-Trefzer, Claudia
Spiliotopoulos, Dimitrios
Gaudio, Eugenio
Tarantelli, Chiara
Dong, Jing
Zhao, Hongtao
Pachmayr, Johanna
Zahler, Stefan
Bernasconi, Elena
Sartori, Giulio
Cascione, Luciano
Bertoni, Francesco
Śledź, Paweł
Caflisch, Amedeo
Nevado Blázquez, Cristina
Ereignis
Veröffentlichung
(wo)
Freiburg
(wer)
Universität
(wann)
2020

DOI
10.1039/D0MD00049C
URN
urn:nbn:de:bsz:25-freidok-1665457
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
25.03.2025, 13:45 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

Entstanden

  • 2020

Ähnliche Objekte (12)